Cargando…
Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
BACKGROUND: Multiple sclerosis (MS) is characterized by a combination of inflammatory and neurodegenerative processes variously dominant in different stages of the disease. Thus, immunosuppression is the goal standard for the inflammatory stage, and novel remyelination therapies are pursued to resto...
Autores principales: | Navarrete, Carmen, Carrillo-Salinas, Francisco, Palomares, Belén, Mecha, Miriam, Jiménez-Jiménez, Carla, Mestre, Leyre, Feliú, Ana, Bellido, Maria L., Fiebich, Bernd L., Appendino, Giovanni, Calzado, Marco A., Guaza, Carmen, Muñoz, Eduardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831753/ https://www.ncbi.nlm.nih.gov/pubmed/29495967 http://dx.doi.org/10.1186/s12974-018-1103-y |
Ejemplares similares
-
VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity
por: Palomares, Belen, et al.
Publicado: (2018) -
Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease
por: Burgaz, Sonia, et al.
Publicado: (2021) -
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways
por: del Río, Carmen, et al.
Publicado: (2016) -
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease
por: Díaz-Alonso, Javier, et al.
Publicado: (2016) -
Viral models of multiple sclerosis: Neurodegeneration and demyelination in mice infected with Theiler's virus
por: Mecha, Miriam, et al.
Publicado: (2013)